- Home
- ATLN vs CYBN Comparison
ATLN vs CYBN Comparison
Compare ATLN & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLN
- CYBN
- Stock Information
- Founded
- ATLN 2014
- CYBN 2019
- Country
- ATLN United States
- CYBN Canada
- Employees
- ATLN N/A
- CYBN N/A
- Industry
- ATLN
- CYBN Pharmaceuticals and Biotechnology
- Sector
- ATLN
- CYBN Health Care
- Exchange
- ATLN NYSE
- CYBN Nasdaq
- Market Cap
- ATLN 137.6M
- CYBN 153.7M
- IPO Year
- ATLN 2021
- CYBN N/A
- Fundamental
- Price
- ATLN $4.20
- CYBN $6.35
- Analyst Decision
- ATLN
- CYBN Strong Buy
- Analyst Count
- ATLN 0
- CYBN 4
- Target Price
- ATLN N/A
- CYBN $86.00
- AVG Volume (30 Days)
- ATLN 76.9K
- CYBN 157.8K
- Earning Date
- ATLN 01-01-0001
- CYBN 02-11-2025
- Dividend Yield
- ATLN N/A
- CYBN N/A
- EPS Growth
- ATLN N/A
- CYBN N/A
- EPS
- ATLN N/A
- CYBN N/A
- Revenue
- ATLN $442,609,814.00
- CYBN N/A
- Revenue This Year
- ATLN N/A
- CYBN N/A
- Revenue Next Year
- ATLN N/A
- CYBN N/A
- P/E Ratio
- ATLN N/A
- CYBN N/A
- Revenue Growth
- ATLN 10.27
- CYBN N/A
- 52 Week Low
- ATLN $1.30
- CYBN $6.20
- 52 Week High
- ATLN $8.98
- CYBN $17.86
- Technical
- Relative Strength Index (RSI)
- ATLN N/A
- CYBN 24.83
- Support Level
- ATLN N/A
- CYBN $7.16
- Resistance Level
- ATLN N/A
- CYBN $7.09
- Average True Range (ATR)
- ATLN 0.00
- CYBN 0.33
- MACD
- ATLN 0.00
- CYBN -0.03
- Stochastic Oscillator
- ATLN 0.00
- CYBN 9.93
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.